ACE2 serum concentrations are reported to be low in connective tissue diseases such as SLE, RA (rheumatoid arthritis), SjS (primary Sjögren's syndrome), and SSc (systemic sclerosis), while an elevated ACE2 level predicts the COVID-19 severity [14,15]. The gene discussed is ACE2; the disease is connective tissue disorder.